Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Tissue Eng ; 10(5-6): 762-70, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15265293

RESUMO

Human ear, nasal, and rib chondrocytes were compared with respect to their suitability to generate autologous cartilage grafts for nonarticular reconstructive surgery. Cells were expanded for two passages in medium containing 10% fetal bovine serum without (control) or with transforming growth factor beta(1) (TGF-beta(1)), fibroblast growth factor 2 (FGF-2), and platelet-derived growth factor bb (PDGF-bb) (TFP). Expanded cells were cultured as three-dimensional pellets in chondrogenic serum-free medium containing insulin, dexamethasone, and TGF-beta(1). Chondrocytes from all three sources were successfully isolated, increased their proliferation rate in response to TFP, and dedifferentiated during passaging. Redifferentiation by ear and nasal, but not rib, chondrocytes was enhanced after TFP expansion, as assessed by the significant increase in glycosaminoglycan (GAG)/DNA content and collagen type II mRNA expression in the resulting pellets. TFP-expanded ear and nasal chondrocytes generated pellets of better quality than rib chondrocytes, as assessed by the significantly higher GAG/DNA content and collagen type II mRNA expression, and by the relative stain intensities for GAG and collagen types I and II. In conclusion, postexpansion cell yields suggest that all three sources investigated could be used to generate autologous grafts of clinically relevant size. However, ear and nasal chondrocytes, if expanded with TFP, display superior postexpansion chondrogenic potential and may be a preferred cell source for cartilage tissue engineering.


Assuntos
Cartilagem/citologia , Cartilagem/crescimento & desenvolvimento , Condrócitos/citologia , Condrócitos/fisiologia , Engenharia Tecidual/métodos , Adolescente , Adulto , Cartilagem/efeitos dos fármacos , Técnicas de Cultura de Células/métodos , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Células Cultivadas , Condrócitos/efeitos dos fármacos , Condrogênese/efeitos dos fármacos , Condrogênese/fisiologia , Cartilagem da Orelha/citologia , Cartilagem da Orelha/efeitos dos fármacos , Cartilagem da Orelha/crescimento & desenvolvimento , Feminino , Substâncias de Crescimento , Humanos , Masculino , Pessoa de Meia-Idade , Nariz/citologia , Nariz/efeitos dos fármacos , Nariz/crescimento & desenvolvimento , Especificidade de Órgãos , Costelas/citologia , Costelas/efeitos dos fármacos , Costelas/crescimento & desenvolvimento , Transplantes
2.
Ann Plast Surg ; 53(1): 44-9, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15211198

RESUMO

Four patients diagnosed with sacral chordoma underwent reconstruction with the gluteus maximus flap using an approach based on available muscle remnants and their residual blood supply. The entire unilateral gluteus maximus muscle was turned over to fill the defect in 2 patients. The flap was based on 1 or 2 gluteal vessels, depending on vessel availability following tumor resection. When all 4 major pedicles had been ligated, bilateral advancement gluteal muscle flaps based on their distal blood supply were used (patient 3). A longitudinally split flap was used for secondary reconstruction of a partially obliterated defect (patient 4). Over a mean follow-up period of 8 months, there was no wound breakdown and all patients were ambulant.


Assuntos
Neoplasias Ósseas/cirurgia , Cordoma/cirurgia , Retalhos Cirúrgicos , Neoplasias Ósseas/patologia , Cordoma/patologia , Feminino , Humanos , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Músculo Esquelético/patologia , Invasividade Neoplásica , Sacro
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA